Celadon Pharmaceuticals PLC Cash Flow Reinvestment Rate

Latest as of June 2020: 1.27x

Celadon Pharmaceuticals PLC cash flow reinvestment rate. Celadon Pharmaceuticals PLC (CEL) has a Cash Flow Reinvestment Rate of 1.27x as of June 2020, reinvesting GBX139.75K (capex GBX139.75K ) from operating cash flow of GBX109.70K. Explore CEL debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

1.27x

(Capex + Investments) / Operating CF

Total Reinvested

GBX139.75K

Capex + Investments

Operating Cash Flow

GBX109.70K

GBX

Capital Expenditures

GBX139.75K

GBX

Cash Flow Reinvestment Rate of Celadon Pharmaceuticals PLC (2019–2019)

Cash flow reinvestment rate of Celadon Pharmaceuticals PLC from 2019 to 2019. Historical reinvestment intensity for Celadon Pharmaceuticals PLC across 1 annual periods. Explore Celadon Pharmaceuticals PLC (CEL) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Celadon Pharmaceuticals PLC Cash Flow Reinvestment Rate by Year (2019–2019)

Celadon Pharmaceuticals PLC cash flow reinvestment rate by year from 2019 to 2019. Year-by-year capital reinvestment analysis for Celadon Pharmaceuticals PLC. For the full cash flow conversion analysis, see how efficiently does Celadon Pharmaceuticals PLC generate cash.

Year	Reinvestment Rate	Total Reinvested (GBX)	Operating CF	Capex	YoY Change
2019	0.00x	GBX0.00	GBX1.98K	GBX0.00	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow